BLOCKADE BY INTRAVENOUS LOSARTAN OF AT1 ANGIOTENSIN II RECEPTORS IN RAT BRAIN, KIDNEY AND ADRENALS DEMONSTRATED BY IN VITRO AUTORADIOGRAPHY

Clinical and Experimental Pharmacology and Physiology

Volumn 21, Issue 7, 1994, Pages 557-567

  Zhuo, Jialong ^a   Song, Keifu ^a   Abdelrahman, Aly ^a   Mendelsohn, Frederick A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

adrenal; angiotensin II receptor; autoradiography; blood brain barrier; brain; kidney; losartan; pharmacology.

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; RENIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; RAT;

ADRENAL GLANDS; ANGIOTENSIN II; ANIMAL; AUTORADIOGRAPHY; BIPHENYL COMPOUNDS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; IN VITRO; INJECTIONS, INTRAVENOUS; KIDNEY; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RENIN; SUPPORT, NON-U.S. GOV'T; TETRAZOLES;

EID: 0027993817     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1994.tb02555.x     Document Type: Article

References (37)

1. Cardiac actions of angiotensin II: role of an intracardiac reninangiotensin system
2. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered PO does not readily cross the blood brain barrier
3. Nomenclature for angiotensin receptors
4. Angiotensin II receptors and mechanisms of action
5. Identification of angiotensin II receptor subtypes
6. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats
7. Angiotensin receptor subtypes of the kidney cortex
8. 2 receptor antagonist WL 19
9. DuP 753: a nonpeptide angiotensin II‐1 receptor antagonist, alters dopaminergic function in the rat striatum
10. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains
11. 125I]‐angiotensin II binding sites in the rat brain: A quantitative autoradiographic study
12. 125I]‐angiotensin II binding sites in the rat brain
13. Molecular biology of the renin‐angiotensin system
14. Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney
15. Regulation of proximal tubule function by angiotensin
16. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay
17. Hormonal response to angiotensin blockade: Comparison between receptor antagonism and converting enzyme inhibition
18. Functional evidence that the angiotensin antagonist losartan crosses the blood‐brain barrier in the rat
19. Thirst and the renin‐angiotensin system
20. Autoradiographic localization of angiotensin II receptor binding in rat brain
21. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats
22. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat
23. The renin angiotensin system: Biochemistry and mechanism of action
24. Functions of angiotensin in the central nervous system
25. Local renin‐angiotensin system in human adrenals and aldosteronomas
26. Pharmacology of nonpeptide angiotensin II receptor antagonists
27. Angiotensin II receptor subtypes in rat brain and peripheral tissues
28. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors
29. Mapping of angiotensin II receptor subtype heterogeneity in rat brain
30. Angiotensin II receptors and angiotensin II receptor antagonists
31. Functional studies of nonpeptide angiotensin II receptor subtype‐specific ligands: DuP 753 (AII‐I) and PD 123177 (AII‐2)
32. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent
33. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent
34. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP 3174: An active metabolite of DuP 753, an orally active antihypertensive agent
35. 2 angiotensin II receptors in rat kidney
36. The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat
37. Intrarenal Angiotensin II Receptors